Phase 3 study of docosahexaenoic acid–paclitaxel versus dacarbazine in patients with metastatic malignant melanoma von Bedikian, A.Y., DeConti, R.C., Conry, R., Agarwala, S., Papadopoulos, N., Kim, K.B., Ernstoff, M.

Volltext

Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma von Algazi, A P, Weber, J S, Andrews, S C, Urbas, P, Munster, P N, DeConti, R C, Hwang, J, Sondak, V K, Messina, J L, McCalmont, T, Daud, A I

Volltext

Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma von DeConti, R C, Algazi, A P, Andrews, S, Urbas, P, Born, O, Stoeckigt, D, Floren, L, Hwang, J, Weber, J, Sondak, V K, Daud, A I

Volltext

Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma von Daud, A. I, Xu, C, Hwu, W.-J, Urbas, P, Andrews, S, Papadopoulos, N. E, Floren, L. C, Yver, A, DeConti, R. C, Sondak, V. K

Volltext

Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin von Heller, Richard, Jaroszeski, Mark J., Reintgen, Douglas S., Puleo, Chris A., DeConti, Ronald C., Gilbert, Richard A., Glass, Lewis F.

Volltext

Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck : an Eastern Cooperative Oncology Group Trial (PA390) von FORASTIERE, A. A, SHANK, D, NEUBERG, D, TAYLOR, S. G, DECONTI, R. C, ADAMS, G

Volltext

Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy von Heller, Richard, Jaroszeski, Mark J., Glass, L. Frank, Messina, Jane L., Rapaport, David P., DeConti, Ronald C., Fenske, Neil A., Gilbert, Richard A., Mir, Lluis M., Reintgen, Douglas S.

Volltext

Phase III Comparison of High-Dose Paclitaxel + Cisplatin + Granulocyte Colony-Stimulating Factor Versus Low-Dose Paclitaxel + Cisplatin in Advanced Head and Neck Cancer: Eastern Co... von FORASTIERE, Arlene A, LEONG, Traci, ROWINSKY, Eric, MURPHY, Barbara A, VLOCK, Daniel R, DECONTI, Ronald C, ADAMS, George L

Volltext

Randomized Phase III Evaluation of Cisplatin Plus Fluorouracil Versus Cisplatin Plus Paclitaxel in Advanced Head and Neck Cancer (E1395): An Intergroup Trial of the Eastern Coopera... von GIBSON, Michael K, YI LI, MURPHY, Barbara, HUSSAIN, Maha H. A, DECONTI, Ronald C, ENSLEY, John, FORASTIERE, Arlene A

Volltext

Concurrent 72-hour continuous infusion of etoposide and cisplatin in metastatic breast cancer von REMICK, S. C, CHMURA, M, BROMBERG, C, SPORN, J, HEALEY, B, HILSTRO, J, DECONTI, R. C, HORTON, J, RUCKDESCHEL, J. C, HARPER, G. R

Volltext

Phase II trial of sagopilone (ZK-EPO), a novel synthetic epothilone, with significant activity in metastatic melanoma von Daud, A., Weber, J., Urbas, P., Andrews, S., Maker, N., Sondak, V. K., DeConti, R. C.

Volltext

Phase II Trial of Karenitecin in Patients with Malignant Melanoma: Clinical and Translational Study von DAUD, Adil, VALKOV, Nikola, HAUSHEER, Frederick, SULLIVAN, Daniel, CENTENO, Barbara, DERDERIAN, Jennifer, SULLIVAN, Patricia, MUNSTER, Pamela, URBAS, Patricia, DECONTI, Ronald C, BERGHORN, Elmer, ZHENMEI LIU

Volltext

Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon [alpha]-2b in patients with resected high-risk melanoma von Daud, A I, Xu, C, Hwu, W-j, Urbas, P, Andrews, S, Papadopoulos, N E, Floren, L C, Yver, A, Deconti, R C, Sondak, V K

Volltext

Phase II trial of sagopilone (ZK-EPO), a novel epothilone, in patients with metastatic melanoma von Wenk, D., DeConti, R. C., Urbas, P., Andrews, S., Sondak, V. K., Maker, N., Weber, J. S., Daud, A. I.

Volltext

Effect of co-morbidity burden on survival following salvage re-irradiation for patients with recurrent or second primary squamous cell carcinoma of the head and neck von Tanvetyanon, T., Padhya, T., McCaffrey, J., Boulware, D., DeConti, R. C., McCaffrey, T., El-Deiry, M., Trotti, A.

Volltext

A phase II trial of imatinib mesylate in Merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group Study (S0331) von Samlowski, W. E., Moon, J., Tuthill, R. J., Heinrich, M. C., Balzer-Haas, N. S., Merl, S. A., DeConti, R. C., Thompson, J. A., Flaherty, L. E., Sondak, V. K.

Volltext

Accuracy of the subrenal capsule xenograft assay in predicting the clinical growth and chemosensitivity of human squamous head and neck carcinomas von Parnes, Steven M., Sagerman, Paul, Bennett, James A., Deconti, Ronald C.

Volltext

A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancer von Deconti, Ronald C., Schoenfeld, David

Volltext

A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin‐D, and cyclophosphamide for advanced sarcoma von Schoenfeld, David A., Rosenbaum, Charles, Horton, John, Wolter, Janet M., Falkson, Geoffrey, Deconti, Ronald C.

Volltext

Expression of STAT proteins and interferon receptors in benign and malignant melanocytic lesions: Correlation with recurrence von Deconti, R. C., Messina, J., Decker, M., Welsh, R., Mora, L., Jove, R., Daud, A.

Volltext